These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28596534)

  • 21. Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
    Basu R; Barosa C; Jones J; Dube S; Carter R; Basu A; Rizza RA
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E409-17. PubMed ID: 23345093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CMPF: A Biomarker for Type 2 Diabetes Mellitus Progression?
    Koppe L; Poitout V
    Trends Endocrinol Metab; 2016 Jul; 27(7):439-440. PubMed ID: 27132217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia.
    Nishi Y; Fukushima M; Suzuki H; Mitsui R; Ueda N; Taniguchi A; Nakai Y; Kawakita T; Kurose T; Seino Y; Yamada Y
    Diabetes Res Clin Pract; 2005 Oct; 70(1):46-52. PubMed ID: 16126123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.
    Daniele G; Winnier D; Mari A; Bruder J; Fourcaudot M; Pengou Z; Hansis-Diarte A; Jenkinson C; Tripathy D; Folli F
    Acta Diabetol; 2018 Feb; 55(2):139-148. PubMed ID: 29151224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive role of altered leptin, adiponectin and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid secretion in gestational diabetes mellitus.
    Florian AR; Cruciat G; Pop RM; Staicu A; Daniel M; Florin S
    Exp Ther Med; 2021 May; 21(5):520. PubMed ID: 33815593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study.
    Miao Z; Zeng FF; Tian Y; Xiao C; Yan Y; Jiang Z; Fu Y; Chen YM; Zheng JS
    Am J Clin Nutr; 2023 Sep; 118(3):637-645. PubMed ID: 37482300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased acyl ghrelin but decreased total ghrelin and unacyl ghrelin in Chinese Han people with impaired fasting glucose combined with impaired glucose tolerance.
    Huang L; Tong Y; Zhang F; Yang Q; Li D; Xie S; Li Y; Cao H; Tang L; Zhang X; Tong N
    Peptides; 2014 Oct; 60():86-94. PubMed ID: 25102450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of islet cell function, insulin sensitivity, and incretin axis between Asian-Indians with either impaired fasting glucose or impaired glucose tolerance, and normal healthy controls.
    Roy A; Kamalanathan S; Sahoo J; Kar SS; Naik D; Narayanan N; Merugu C; Patel D
    Diabetes Res Clin Pract; 2021 Jun; 176():108846. PubMed ID: 33951481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced renal clearance of furancarboxylic acid, a major albumin-bound organic acid, in undialyzed uremic patients.
    Sato M; Koyama M; Miyazaki T; Niwa T
    Nephron; 1996; 74(2):419-21. PubMed ID: 8893167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of plasma 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease.
    Ono H; Tanaka R; Suzuki Y; Oda A; Sato H; Tatsuta R; Ando T; Shin T; Ohno K; Itoh H
    Clin Transl Sci; 2024 Feb; 17(2):e13731. PubMed ID: 38564661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.
    Tsutsumi Y; Maruyama T; Takadate A; Shimada H; Otagiri M
    Nephron; 2000 May; 85(1):60-4. PubMed ID: 10773757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic beta-cell function and fetal growth in gestational impaired glucose tolerance.
    Miyakoshi K; Tanaka M; Saisho Y; Shimada A; Minegishi K; Kim SH; Asai S; Itoh H; Yoshimura Y
    Acta Obstet Gynecol Scand; 2010 Jun; 89(6):769-75. PubMed ID: 20504080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Furan fatty acids - Beneficial or harmful to health?
    Xu L; Sinclair AJ; Faiza M; Li D; Han X; Yin H; Wang Y
    Prog Lipid Res; 2017 Oct; 68():119-137. PubMed ID: 29051014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cardiovascular disease and risk factors in the Chinese population with impaired glucose regulation: the 2007-2008 China national diabetes and metabolic disorders study.
    Yang Z; Xing X; Xiao J; Lu J; Weng J; Jia W; Ji L; Shan Z; Liu J; Tian H; Ji Q; Zhu D; Ge J; Lin L; Chen L; Guo X; Zhao Z; Li Q; Zhou Z; Shan G; Yang W;
    Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):372-4. PubMed ID: 23616189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.
    Meyer C; Pimenta W; Woerle HJ; Van Haeften T; Szoke E; Mitrakou A; Gerich J
    Diabetes Care; 2006 Aug; 29(8):1909-14. PubMed ID: 16873801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese.
    Oka R; Yagi K; Sakurai M; Nakamura K; Moriuchi T; Miyamoto S; Nohara A; Kawashiri MA; Takeda Y; Yamagishi M
    Endocr J; 2012; 59(1):55-64. PubMed ID: 22068110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial.
    Zheng JS; Lin M; Imamura F; Cai W; Wang L; Feng JP; Ruan Y; Tang J; Wang F; Yang H; Li D
    Sci Rep; 2016 Jul; 6():29522. PubMed ID: 27404516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.